RNA epigenetics is perhaps the most recent aspect of interest for translational epigeneticists. RNA modifications create such an extensive network of epigenetically driven combination whose role in physiology and pathophysiology is still far from being elucidated. Not surprisingly, some of the players determining changes into RNA structure are in common with those involved in DNA and chromatin structure regulation, while other molecules seem very specific to RNA. It is envisaged, then, that new small molecules, acting selectively on RNA epigenetic changes, will be reported soon, opening new therapeutic interventions based on the correction of the RNA epigenetic landscape. In this review, we shall summarize some aspects of RNA epigenetics limited to those in which the potential clinical translatability to cardiovascular disease is emerging. 2 classification is not predictive of ncRNAs function. Indeed, Amaral et al. have proposed a new way 43
Introduction 24
Translational epigenetics is a relatively new branch of molecular biology that investigates 25 regulatory processes occurring molecularly "above" the primary DNA sequence associated with 26 physiological and pathophysiological conditions. Specifically, of applied translational epigenetics 27
interest are those mechanisms that introduce functional changes into DNA, RNA, and sometimes 28 proteins, without introducing changes into their primary sequence, and with essential implications 29 in organismal function and disease. Hence, translational epigenetics pays attention to the effect of 30 chemical modifications on DNA [1], histones, non-histone proteins [2], and RNA [3] , which in turn 31 result in structural and functional changes of target molecules especially when these molecules may 32
be of therapeutic interest. The object of this review is to explore epigenetic modifications particularly 33 relevant to RNA biology with a particular focus on those crucial in cardiovascular physiology and 34 pathophysiology. For a general description of the regulation and the effects of epigenetic changes 35 occurring at RNA level, the reader is redirected to recent articles that are more detailed in mechanistic 36 terms [4] [5] [6] [7] . 37 Among the different RNA species, there are non-coding RNAs (ncRNAs), which are ribonucleic 38 acid sequences that do not codify for proteins. They recently became of interest for their important 39 regulatory function and perspective diagnostic-therapeutic potential. Conventionally, ncRNAs are 40 classified by their length: 200 nucleotides are the cut off between long (lncRNAs) and short non- 41 coding RNAs (sncRNAs). The latter group includes microRNAs (miRNAs) [8] . However, this 42 between the abundance of m 6 A in RNA and the increase in cellular volume [37] . In failing hearts, one 115 example is given by the m 6 A hypermethylation of mRNA encoding for Myosin regulatory light chain 116 2 (Myl2) resulting in lower protein levels than healthy controls [37], suggesting in this case for a 117 destabilizing effect of m 6 A (see figure 5 ). The destabilizing effect, however, seems context-dependent 118 or, perhaps, associated with specific pathophysiological conditions. Often, in fact, the presence of 119 atherosclerotic plaques correlates with inflammation and macrophages infiltration [38] . A recent 120 work reported about an epigenetic mechanism regulating macrophage function [39] . In this context, 121
METTL3 methylated the signal transducer and activator of transcription 1 (STAT1) mRNA in M1 122
macrophages [39] . The regions of STAT1 more prone to modification were the coding sequence and 123 the 3'-untranslated region overall increasing the relative mRNA stability [39] . As a result, the 124 methylation of STAT1 mRNA, increasing STAT1 translation and activity, seemed driving M1 125 macrophage polarization, defining a potentially novel anti-inflammatory signalling pathway [39], 126 (see figure 4) . 
129
Positive effects have been reported on MAPK and STAT1 mRNAs whose translation was enhanced.
130
In addition, the methylation in specific ApC sequences on MALAT 1, increases the interaction with 131 HNRG proteins contributing to the alternative splicing. 
138
Inflammatory signals are at the basis of all chronic diseases and they are often triggered by 139 dysmetabolic conditions associated with aging, a process widely defined as inflammaging [40] . In an 140 experimental model of prolonged hyperglycemia and cardiomyopathy, high levels of the metastasis-141 associated lung adenocarcinoma transcript-1 lncRNA (MALAT1) have been reported [41] . In this 142 condition, the inhibition of phosphodiesterase 5, through the administration of sildenafil, resulted in an 143
increase of nitric oxide that normalized MALAT1 levels in cardiomyocytes by an unknown mechanism [41] . 144
Interestingly, MALAT1 transcript has multiple sites of adenosine methylation especially on consensus 145 sequences such as GGACU, AGACA, and GAACC [42] . Such modification introduced conformational changes 146
in the RNA molecule promoting its association with multiple RNA binding proteins [43] . As 4) . 154 In the context of regulatory processes, it emerged clearly that positive and negative feedback 155 loops are present during the process of RNA maturation in which methylation might play a role at 156 different levels. For example, the expression of miRNAs is frequently regulated by methylation of the 157 corresponding DNA locus. 6) . 
Methylation at ncRNA promoters and its consequences for CVDs 206
HHcy is also a condition where the methylation of lncRNA H19 plays an important regulatory 207 role [57] . In fact, in rodents, the differentially methylated domain located in H19 promoter results 208 hypomethylated in the presence of HHcy, altering the expression of H19 and that of insulin growth 209 factor 2 (IGF2) which is located in proximity [57]. In rats, HHcy determines tissue-specific alterations 210 of methylation at the level of the H19 promoter. In particular, H19 promoter methylation has been 211 observed in rat aorta, while low levels have been found in the liver [ In summary, the methylation of H19 locus has effects on H19 expression and function and 222
interferes 
